DK0412766T3 - Peptidfragmenter af HIV - Google Patents

Peptidfragmenter af HIV

Info

Publication number
DK0412766T3
DK0412766T3 DK90308662.7T DK90308662T DK0412766T3 DK 0412766 T3 DK0412766 T3 DK 0412766T3 DK 90308662 T DK90308662 T DK 90308662T DK 0412766 T3 DK0412766 T3 DK 0412766T3
Authority
DK
Denmark
Prior art keywords
proline
hiv
peptide
isoleucine
fragment
Prior art date
Application number
DK90308662.7T
Other languages
English (en)
Inventor
Andrew James Mcmichael
Douglas Fraser Nixon
Alain Robert Michael Townsend
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43806939&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0412766(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Application granted granted Critical
Publication of DK0412766T3 publication Critical patent/DK0412766T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90308662.7T 1989-08-09 1990-08-07 Peptidfragmenter af HIV DK0412766T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898918200A GB8918200D0 (en) 1989-08-09 1989-08-09 The peptide fragments of hiv

Publications (1)

Publication Number Publication Date
DK0412766T3 true DK0412766T3 (da) 1994-07-18

Family

ID=43806939

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90308662.7T DK0412766T3 (da) 1989-08-09 1990-08-07 Peptidfragmenter af HIV

Country Status (12)

Country Link
US (1) US5700635A (da)
EP (1) EP0412766B1 (da)
JP (1) JPH04507100A (da)
AT (1) ATE103294T1 (da)
CA (1) CA2064691A1 (da)
DE (1) DE69007571T2 (da)
DK (1) DK0412766T3 (da)
ES (1) ES2054256T3 (da)
GB (2) GB8918200D0 (da)
HK (1) HK141494A (da)
SG (1) SG130094G (da)
WO (1) WO1991001996A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
ATE134195T1 (de) * 1988-06-10 1996-02-15 United Biomedical Inc Peptidfragmente von hiv
WO1991009869A1 (en) * 1990-01-05 1991-07-11 Medical Research Council Hiv-1 core protein fragments
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
CN1055701C (zh) * 1993-10-19 2000-08-23 味之素株式会社 能诱导对hiv免疫应答的肽及含有该肽的预防、治疗aids的药物
GB9426153D0 (en) * 1994-12-23 1995-02-22 Medical Res Council Improvements in or relating to vaccines
MXPA02006379A (es) * 1999-12-23 2004-06-21 Medical Res Council Mejoriasen o relacionadas con la respuesta inmune a vih.
CU23235A1 (es) * 2001-02-28 2007-09-26 Ct Ingenieria Genetica Biotech POXVIRUS RECOMBINANTES PARA PROTEINAS QUIMéRICAS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA Y SU APLICACION EN LA TERAPéUTICA Y LA PREVENCION DEL SIDA
EP2277161A2 (en) * 2008-04-24 2011-01-26 Avery Dennison Corporation Sheet having removable labels and related method
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62164696A (ja) * 1986-01-06 1987-07-21 エフ.ホフマン ― ラ ロシュ アーゲー HTLV−3gag遺伝子の発現
NO881151L (no) * 1987-03-27 1988-09-28 Syntello Ab Syntetisk hiv-1-antigen.
EP0330359A3 (en) * 1988-02-25 1991-06-05 Bio-Rad Laboratories, Inc. Composition useful in the diagnosis and treating of hiv-1 infection

Also Published As

Publication number Publication date
DE69007571T2 (de) 1994-09-08
EP0412766B1 (en) 1994-03-23
EP0412766A1 (en) 1991-02-13
GB2250994A (en) 1992-06-24
GB9201468D0 (en) 1992-04-01
JPH04507100A (ja) 1992-12-10
HK141494A (en) 1994-12-23
ES2054256T3 (es) 1994-08-01
CA2064691A1 (en) 1991-02-10
GB8918200D0 (en) 1989-09-20
WO1991001996A1 (en) 1991-02-21
ATE103294T1 (de) 1994-04-15
DE69007571D1 (de) 1994-04-28
SG130094G (en) 1995-01-13
US5700635A (en) 1997-12-23
GB2250994B (en) 1993-08-25

Similar Documents

Publication Publication Date Title
GB2255093A (en) Hiv-1 core protein fragments
ATE373010T1 (de) Gag-antigen und dessen verwendung zum nachweis von lav-infektion, sowie in immunogenen zusammensetzungen
FI950405A (fi) Heikosti immunogeenisten antigeenien ja synteettisten peptidikantajien konjugaatit sekä niitä sisältävät rokotteet
ATE127345T1 (de) Stressproteine und verwendungen dafür.
DE68925660D1 (de) Peptidfragmente von HIV
DK0412766T3 (da) Peptidfragmenter af HIV
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
ATE185148T1 (de) Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
NZ224251A (en) Synthetic rhinovirus (hrv) peptides and vaccines
ES2071038T3 (es) Peptidos asociados al hiv.
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
ES2061944T3 (es) Conjugado de peptido inmunologicamente activo ppd (nanp)n util como vacuna antimalaria.